Scintomics Molecular ATT
Scintomics Molecular, Applied Theranostics Technologies (ATT)
Scintomics Molecular, Applied Theranostics Technologies (ATT) is a growing player in the radiopharmaceutical business with a particular strategic emphasis on providing unrestricted supply and support of proprietary and innovative tracer technology and non-IP protected precursors, such as PSMA I&T (patent protected in several EU countries and Au
It looks like we’re having a few problems here.
Please reload to try again.